Cargando…
Interval between Removal of a 4.7 mg Deslorelin Implant after a 3-, 6-, and 9-Month Treatment and Restoration of Testicular Function in Tomcats
SIMPLE SUMMARY: Gonadotropin-releasing hormone (GnRH) agonists bind to GnRH receptors in the anterior pituitary causing an initial release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) followed by a desensibilization of the GnRH receptors. On the first days of treatment, this re...
Autores principales: | Ferré-Dolcet, Lluis, Carniello, Lisa, Ferro, Silvia, Cattai, Andrea, Romagnoli, Stefano, Mollo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7552215/ https://www.ncbi.nlm.nih.gov/pubmed/32887474 http://dx.doi.org/10.3390/ani10091559 |
Ejemplares similares
-
Anti-Müllerian Hormone Concentrations for Determining Resumption of Sertoli Cell Function following Removal of a 4.7 mg Deslorelin Implant in Tomcats
por: Ferré-Dolcet, Lluis, et al.
Publicado: (2023) -
Chronic Use of Deslorelin in Dogs: Six Cases (2005–2022)
por: Romagnoli, Stefano, et al.
Publicado: (2023) -
What Happens in Male Dogs after Treatment with a 4.7 mg Deslorelin Implant? II. Recovery of Testicular Function after Implant Removal
por: Stempel, Sabrina, et al.
Publicado: (2022) -
Testicular Expression of Antioxidant Enzymes and Changes in Response to a Slow-Release Deslorelin Implant (Suprelorin(®) 4.7 mg) in the Dog
por: Gram, Duygu Yaman, et al.
Publicado: (2022) -
Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant
por: Romagnoli, Stefano, et al.
Publicado: (2018)